CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer

BACKGROUND: Breast cancer is the leading cause of mortality from cancer in women worldwide, and cancer stem-like cell (CSC) is responsible for failure treatment of breast cancer. It plays an important role in resistant disease and metastasis. CD44/CD24 and ALDH are well-accepted protein markers of b...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuyi, Tu, Li, Du, Chi, Xie, Xiaoxiao, Liu, Yanyang, Wang, Jiantao, Li, Zhixi, Jiang, Ming, Cao, Dan, Yan, Xi, Luo, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134958/
https://www.ncbi.nlm.nih.gov/pubmed/30233217
http://dx.doi.org/10.2147/OTT.S174329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134958/
https://www.ncbi.nlm.nih.gov/pubmed/30233217
http://dx.doi.org/10.2147/OTT.S174329

Ejemplares similares